...
首页> 外文期刊>Molecular and Cellular Biology >Stabilization of ATF5 by TAK1–Nemo-Like Kinase Critically Regulates the Interleukin-1β-Stimulated C/EBP Signaling Pathway
【24h】

Stabilization of ATF5 by TAK1–Nemo-Like Kinase Critically Regulates the Interleukin-1β-Stimulated C/EBP Signaling Pathway

机译:TAK1-Nemo-like激酶稳定ATF5关键性调节白介素1β刺激的C / EBP信号通路。

获取原文
           

摘要

Interleukin-1β (IL-1β) is a key proinflammatory cytokine that initiates several signaling cascades, including those involving CCAAT/enhancer binding proteins (C/EBPs). The mechanism by which IL-1β propagates a signal that activates C/EBP has remained elusive. Nemo-like kinase (NLK) is a mitogen-activated protein kinase (MAPK)-like kinase associated with many pathways and phenotypes that are not yet well understood. Using a luciferase reporter screen, we found that IL-1β-induced C/EBP activation was positively regulated by NLK. Overexpression of NLK activated C/EBP and potentiated IL-1β-triggered C/EBP activation, whereas knockdown or knockout of NLK had the opposite effect. NLK interacted with activating transcription factor 5 (ATF5) and inhibited the proteasome-dependent degradation of ATF5 in a kinase-independent manner. Consistently, NLK deficiency resulted in decreased levels of ATF5. NLK cooperated with ATF5 to activate C/EBP, whereas NLK could not activate C/EBP upon knockdown of ATF5. Moreover, TAK1, a downstream effector of IL-1β that acts upstream of NLK, mimicked the ability of NLK to stabilize ATF5 and activate C/EBP. Thus, our findings reveal the TAK1-NLK pathway as a novel regulator of basal or IL-1β-triggered C/EBP activation though stabilization of ATF5.
机译:白介素-1β(IL-1β)是一种重要的促炎细胞因子,可引发多种信号级联反应,包括涉及CCAAT /增强子结合蛋白(C / EBPs)的级联反应。 IL-1β传播激活C / EBP的信号的机制仍然难以捉摸。 Nemo-like激酶(NLK)是一种与许多尚未充分了解的途径和表型相关的促分裂原活化蛋白激酶(MAPK)-样激酶。使用萤光素酶报道分子筛选,我们发现NLK正调控IL-1β诱导的C / EBP激活。 NLK的过表达激活C / EBP和IL-1β触发的C / EBP增强激活,而敲除或敲除NLK具有相反的作用。 NLK与活化转录因子5(ATF5)相互作用,并以激酶非依赖性方式抑制ATF5的蛋白酶体依赖性降解。一致地,NLK缺乏导致ATF5水平降低。 NLK与ATF5合作激活C / EBP,而NLK在ATF5敲低后无法激活C / EBP。此外,TAK1(IL-1β的下游效应物,在NLK的上游起作用)模仿了NLK稳定ATF5和激活C / EBP的能力。因此,我们的发现揭示了TAK1-NLK途径是通过ATF5稳定而作为基础或IL-1β触发的C / EBP激活的新型调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号